Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection
Clinical trial NCT03269162 · UNKNOWN
Trial details
- NCT number
- NCT03269162
- Sponsor
- lihegen
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-30
- Primary completion
- 2019-09-30
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.